Global Hematology Analyzers and Reagents Market 2024-2028

The hematology analyzers and reagents market is forecasted to grow by USD 3911.6 mn during 2023-2028, accelerating at a CAGR of 6.95% during the forecast period. The report on the hematology analyzers and reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase adoption of hematology analyzer solutions for smaller and mid-sized laboratories, growing adoption of point-of-care testing, and increasing demand for personalized medicines.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	6.54%
CAGR	6.95%
Incremental Value	$3911.6mn

Technavio's hematology analyzers and reagents market is segmented as below:

By Product

Reagents and consumables
Instruments

By End-user

Hospitals
Clinical laboratories
Research institute
Others

By Geographical Landscape

North America
Asia
Europe
Rest of World (ROW)

This study identifies the increasing use of automated systems in healthcare sector as one of the prime reasons driving the hematology analyzers and reagents market growth during the next few years. Also, increasing prevalence of blood disorders and increased healthcare expenditure will lead to sizable demand in the market.

The report on the hematology analyzers and reagents market covers the following areas:

Hematology analyzers and reagents market sizing
Hematology analyzers and reagents market forecast
Hematology analyzers and reagents market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hematology analyzers and reagents market vendors that include Abbott Laboratories, Bio Rad Laboratories Inc., BioSystems SA, Boule Diagnostics AB, Danaher Corp., EKF Diagnostics Holdings Plc, Erba Diagnostics FZ LLC, F. Hoffmann La Roche Ltd., Heska Corp., HORIBA Ltd., Mindray Bio medical Electronics Co. Ltd., NeoMedica, Nihon Kohden Corp., Siemens AG, STRATEC SE, Sysmex Corp., Thermo Fisher Scientific Inc., Toyobo Co. Ltd., URIT Medical Electronic Co. Ltd., and Zoetis Inc.. Also, the hematology analyzers and reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR76795

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global hematology analyzers and reagents market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global hematology analyzers and reagents market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Reagents and consumables - Market size and forecast 2023-2028
Exhibit 34: Chart on Reagents and consumables - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Reagents and consumables - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Reagents and consumables - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Reagents and consumables - Year-over-year growth 2023-2028 (%)
6.4 Instruments - Market size and forecast 2023-2028
Exhibit 38: Chart on Instruments - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Instruments - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Instruments - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Instruments - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2023-2028
Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
7.4 Clinical laboratories - Market size and forecast 2023-2028
Exhibit 52: Chart on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Clinical laboratories - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Clinical laboratories - Year-over-year growth 2023-2028 (%)
7.5 Research institute - Market size and forecast 2023-2028
Exhibit 56: Chart on Research institute - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Research institute - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Research institute - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Research institute - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ million)
Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.5 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.10 Germany - Market size and forecast 2023-2028
Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
12.4 Bio Rad Laboratories Inc.
Exhibit 120: Bio Rad Laboratories Inc. - Overview
Exhibit 121: Bio Rad Laboratories Inc. - Business segments
Exhibit 122: Bio Rad Laboratories Inc. - Key news
Exhibit 123: Bio Rad Laboratories Inc. - Key offerings
Exhibit 124: Bio Rad Laboratories Inc. - Segment focus
12.5 BioSystems SA
Exhibit 125: BioSystems SA - Overview
Exhibit 126: BioSystems SA - Product / Service
Exhibit 127: BioSystems SA - Key offerings
12.6 Boule Diagnostics AB
Exhibit 128: Boule Diagnostics AB - Overview
Exhibit 129: Boule Diagnostics AB - Product / Service
Exhibit 130: Boule Diagnostics AB - Key offerings
12.7 Danaher Corp.
Exhibit 131: Danaher Corp. - Overview
Exhibit 132: Danaher Corp. - Business segments
Exhibit 133: Danaher Corp. - Key news
Exhibit 134: Danaher Corp. - Key offerings
Exhibit 135: Danaher Corp. - Segment focus
12.8 EKF Diagnostics Holdings Plc
Exhibit 136: EKF Diagnostics Holdings Plc - Overview
Exhibit 137: EKF Diagnostics Holdings Plc - Business segments
Exhibit 138: EKF Diagnostics Holdings Plc - Key offerings
Exhibit 139: EKF Diagnostics Holdings Plc - Segment focus
12.9 F. Hoffmann La Roche Ltd.
Exhibit 140: F. Hoffmann La Roche Ltd. - Overview
Exhibit 141: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 142: F. Hoffmann La Roche Ltd. - Key news
Exhibit 143: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 144: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Heska Corp.
Exhibit 145: Heska Corp. - Overview
Exhibit 146: Heska Corp. - Business segments
Exhibit 147: Heska Corp. - Key news
Exhibit 148: Heska Corp. - Key offerings
Exhibit 149: Heska Corp. - Segment focus
12.11 HORIBA Ltd.
Exhibit 150: HORIBA Ltd. - Overview
Exhibit 151: HORIBA Ltd. - Business segments
Exhibit 152: HORIBA Ltd. - Key offerings
Exhibit 153: HORIBA Ltd. - Segment focus
12.12 Mindray Bio medical Electronics Co. Ltd.
Exhibit 154: Mindray Bio medical Electronics Co. Ltd. - Overview
Exhibit 155: Mindray Bio medical Electronics Co. Ltd. - Product / Service
Exhibit 156: Mindray Bio medical Electronics Co. Ltd. - Key offerings
12.13 Nihon Kohden Corp.
Exhibit 157: Nihon Kohden Corp. - Overview
Exhibit 158: Nihon Kohden Corp. - Product / Service
Exhibit 159: Nihon Kohden Corp. - Key news
Exhibit 160: Nihon Kohden Corp. - Key offerings
12.14 Siemens AG
Exhibit 161: Siemens AG - Overview
Exhibit 162: Siemens AG - Business segments
Exhibit 163: Siemens AG - Key news
Exhibit 164: Siemens AG - Key offerings
Exhibit 165: Siemens AG - Segment focus
12.15 STRATEC SE
Exhibit 166: STRATEC SE - Overview
Exhibit 167: STRATEC SE - Business segments
Exhibit 168: STRATEC SE - Key offerings
Exhibit 169: STRATEC SE - Segment focus
12.16 Sysmex Corp.
Exhibit 170: Sysmex Corp. - Overview
Exhibit 171: Sysmex Corp. - Business segments
Exhibit 172: Sysmex Corp. - Key offerings
Exhibit 173: Sysmex Corp. - Segment focus
12.17 Zoetis Inc.
Exhibit 174: Zoetis Inc. - Overview
Exhibit 175: Zoetis Inc. - Business segments
Exhibit 176: Zoetis Inc. - Key news
Exhibit 177: Zoetis Inc. - Key offerings
Exhibit 178: Zoetis Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 179: Inclusions checklist
Exhibit 180: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 181: Currency conversion rates for US$
13.4 Research methodology
Exhibit 182: Research methodology
Exhibit 183: Validation techniques employed for market sizing
Exhibit 184: Information sources
13.5 List of abbreviations
Exhibit 185: List of abbreviations